FDA Recalls Thousands Of Duloxetine Antidepressant Bottles | Here's Why

The US Food and Drug Administration has recalled thousands of bottles of Duloxetine antidepressant, saying it contained high levels of a cancer-causing chemical. The federal agency has reportedly upgraded the level of risk. According to agency records reported by NJ.com, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, which is produced by Towa Pharmaceutical Europe.